Reyataz and Weakness - from FDA reports


Summary

Weakness is found among people who take Reyataz, especially for people who are male, 40-49 old , have been taking the drug for < 1 month, also take medication Norvir, and have Hepatitis c. This review analyzes which people have Weakness with Reyataz. It is created by eHealthMe based on reports of 8,570 people who have side effects when taking Reyataz from FDA , and is updated regularly.

What to expect?

If you take Reyataz and have Weakness, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Reyataz and have Weakness

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Aug, 27, 2017

8,570 people reported to have side effects when taking Reyataz.
Among them, 197 people (2.3%) have Weakness


Number of reports submitted per year:

Could Reyataz cause Weakness?

Time on Reyataz when people have Weakness *:

  • < 1 month: 35.59 %
  • 1 - 6 months: 22.03 %
  • 6 - 12 months: 16.95 %
  • 1 - 2 years: 10.17 %
  • 2 - 5 years: 10.17 %
  • 5 - 10 years: 5.08 %
  • 10+ years: 0.0 %

Gender of people who have Weakness when taking Reyataz *:

  • female: 36.13 %
  • male: 63.87 %

Age of people who have Weakness when taking Reyataz *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.14 %
  • 30-39: 13.61 %
  • 40-49: 44.38 %
  • 50-59: 27.22 %
  • 60+: 10.65 %

Top conditions involved for these people *:

  • Hepatitis C (16 people, 8.12%)
  • High Blood Pressure (11 people, 5.58%)
  • Preventive Health Care (7 people, 3.55%)
  • Schizophrenia (5 people, 2.54%)
  • Depression (4 people, 2.03%)

Top co-used drugs for these people *:

  • Norvir (126 people, 63.96%)
  • Truvada (76 people, 38.58%)
  • Viread (37 people, 18.78%)
  • Videx (26 people, 13.20%)
  • Epivir (23 people, 11.68%)

Top other side effects for these people *:

  • Fever (37 people, 18.78%)
  • Nausea (35 people, 17.77%)
  • Weight Decreased (28 people, 14.21%)
  • Fatigue (27 people, 13.71%)
  • Nausea And Vomiting (26 people, 13.20%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Weakness when taking Reyataz?

Expand the study to include all drugs with the same ingredients

Weakness and drugs with ingredients of atazanavir sulfate.

Expand the study to include reports from both FDA and eHealthMe

Weakness and Reyataz from FDA and eHealthMe reports

Reyataz

Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. (latest outcomes from Reyataz 8,724 users)

Weakness

Weakness has been reported by people with multiple sclerosis, high blood pressure, high blood cholesterol (latest reports from 303,639 Weakness patients).

Browse all side effects of Reyataz

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Weakness

Weakness

Could your condition cause Weakness

Weakness

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Reyataz and have Weakness.

Questions to the study

More questions >

User reviews to the study

More reviews >